Cardiac fibroblast activation and hyaluronan synthesis in response to hyperglycemia and diet-induced insulin resistance.
Animal Feed
Animals
Diabetes Mellitus, Type 1
/ metabolism
Diabetes Mellitus, Type 2
/ metabolism
Diabetic Cardiomyopathies
/ pathology
Disease Models, Animal
Disease Progression
Extracellular Matrix
/ metabolism
Fibroblasts
/ metabolism
Fibrosis
Hyaluronic Acid
/ metabolism
Hyperglycemia
/ metabolism
Inflammation
Insulin Resistance
Male
Mice
Mice, Inbred C57BL
Myocardium
/ metabolism
Obesity
/ complications
Transforming Growth Factor beta1
/ metabolism
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
12 02 2019
12 02 2019
Historique:
received:
05
04
2018
accepted:
16
10
2018
entrez:
14
2
2019
pubmed:
14
2
2019
medline:
24
9
2020
Statut:
epublish
Résumé
Diabetic patients are at a greater risk of heart failure due to diabetic cardiomyopathy and worsened outcome post-myocardial infarction. While the molecular mechanisms remain unclear, fibrosis and chronic inflammation are common characteristics of both conditions. Diabetes mellitus (types I and II) results in excessive hyaluronan (HA) deposition in vivo, and hyperglycemia stimulates HA synthesis for several cell types in vitro. HA-rich extracellular matrix contributes to fibrotic, hyperplastic and inflammatory disease progression. We hypothesized that excessive hyperglycemia-driven HA accumulation may contribute to pathological fibroblast activation and fibrotic remodelling in diabetic patients. Therefore, we analysed the impact of both hyperglycemia and diet-induced obesity and insulin resistance on HA matrix formation and cardiac fibroblast activation. Here we report that cardiac fibroblasts isolated from mice on a diabetogenic diet acquire pro-fibrotic gene expression without a concomitant increase in HA matrix deposition. Additionally, hyperglycemia alone does not stimulate HA synthesis or cardiac fibroblast activation in vitro, suggesting that the direct effect of hyperglycemia on fibroblasts is not the primary driver of fibrotic remodelling in cardiac diabetic maladaptation.
Identifiants
pubmed: 30755628
doi: 10.1038/s41598-018-36140-6
pii: 10.1038/s41598-018-36140-6
pmc: PMC6372628
doi:
Substances chimiques
Tgfb1 protein, mouse
0
Transforming Growth Factor beta1
0
Hyaluronic Acid
9004-61-9
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1827Références
Kidney Int. 2001 May;59(5):1739-49
pubmed: 11318944
Metabolism. 2001 Jul;50(7):789-94
pubmed: 11436183
Endocrinology. 2001 Dec;142(12):5267-76
pubmed: 11713226
Hypertension. 2002 Mar 1;39(3):756-60
pubmed: 11897758
J Biol Chem. 2003 Mar 21;278(12):10022-7
pubmed: 12510058
J Diabetes Complications. 2003 Nov-Dec;17(6):355-64
pubmed: 14583181
J Biol Chem. 2004 Mar 12;279(11):10279-85
pubmed: 14679194
Ukr Biokhim Zh (1999). 2003 Sep-Oct;75(5):55-62
pubmed: 14681993
Metabolism. 2004 Jun;53(6):710-5
pubmed: 15164316
Biochim Biophys Acta. 2004 Jul 6;1673(1-2):13-28
pubmed: 15238246
Biochem Biophys Res Commun. 1991 Jun 28;177(3):1095-100
pubmed: 1711843
Mol Cell Biochem. 2007 Jul;301(1-2):109-14
pubmed: 17206378
Am J Physiol. 1991 Dec;261(6 Pt 2):H1698-705
pubmed: 1750528
Circulation. 2008 Jan 1;117(1):43-51
pubmed: 18071071
Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1675-84
pubmed: 18296558
Eur Heart J. 2008 Jun;29(11):1377-85
pubmed: 18413309
Connect Tissue Res. 2008;49(3):115-9
pubmed: 18661324
J Biol Chem. 2009 Jun 12;284(24):16621-32
pubmed: 19276076
J Hypertens. 2010 Feb;28(2):340-52
pubmed: 19864959
J Biol Chem. 1991 Mar 15;266(8):4706-12
pubmed: 2002019
Glycobiology. 2010 Sep;20(9):1117-26
pubmed: 20488939
J Biol Chem. 2011 May 20;286(20):17618-30
pubmed: 21454519
Clin Exp Pharmacol Physiol. 2011 Jun;38(6):387-94
pubmed: 21457293
J Exp Med. 2011 Jul 4;208(7):1459-71
pubmed: 21708929
Diabetes. 2013 Jun;62(6):1888-96
pubmed: 23349492
Am J Physiol. 1990 May;258(5 Pt 2):H1274-80
pubmed: 2337162
J Clin Invest. 2013 Mar;123(3):1359-70
pubmed: 23434587
Cell Biochem Biophys. 2013 Nov;67(2):583-90
pubmed: 23479332
Cardiovasc Res. 2013 Jul 1;99(1):164-74
pubmed: 23580606
J Biol Chem. 2013 May 24;288(21):14824-38
pubmed: 23589287
Circ Res. 2013 Aug 16;113(5):603-16
pubmed: 23948585
PLoS One. 2013 Aug 21;8(8):e72080
pubmed: 23991045
Biochim Biophys Acta. 2013 Dec;1832(12):2414-24
pubmed: 24036209
Exp Cell Res. 2014 Jan 1;320(1):153-63
pubmed: 24099991
J Biol Chem. 2014 Mar 28;289(13):9418-29
pubmed: 24482224
Matrix Biol. 2014 Apr;35:14-7
pubmed: 24486448
Diabetes. 2014 Aug;63(8):2727-43
pubmed: 24677718
Am J Physiol Heart Circ Physiol. 2014 Sep 1;307(5):H762-72
pubmed: 24993041
Biochim Biophys Acta. 2014 Nov;1843(11):2603-10
pubmed: 25072659
J Biol Chem. 2014 Oct 17;289(42):28816-26
pubmed: 25183006
Basic Res Cardiol. 2014;109(6):440
pubmed: 25236954
Circulation. 2015 Sep 8;132(10):923-31
pubmed: 26152709
J Clin Invest. 2015 Oct 1;125(10):3928-40
pubmed: 26368307
J Mol Cell Cardiol. 2016 Jan;90:84-93
pubmed: 26705059
J Diabetes Complications. 2016 May-Jun;30(4):563-72
pubmed: 26908090
Sci Rep. 2016 Mar 14;6:23010
pubmed: 26972749
J Clin Lab Anal. 2017 Jan;31(1):
pubmed: 27306798
Circ Res. 2016 Oct 28;119(10):1116-1127
pubmed: 27601479
Circ J. 2016 Oct 25;80(11):2269-2276
pubmed: 27746422
Cardiovasc Res. 2017 Mar 15;113(4):411-421
pubmed: 28395011
Int J Cancer. 2017 Aug 15;141(4):791-804
pubmed: 28493326
Oxid Med Cell Longev. 2017;2017:3724545
pubmed: 28947927
Int J Cardiol. 2018 Feb 1;252:163-166
pubmed: 29249425
Methods Cell Biol. 2018;143:297-316
pubmed: 29310784
J Cell Mol Med. 2018 Mar;22(3):1816-1825
pubmed: 29314607
Nat Rev Cardiol. 2018 Aug;15(8):457-470
pubmed: 29915254
PLoS Biol. 2018 Jun 21;16(6):e2004408
pubmed: 29927970
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H934-H949
pubmed: 30004258
Diabetologia. 1994 Mar;37(3):286-92
pubmed: 8174843
Circulation. 1997 Jan 21;95(2):415-22
pubmed: 9008459